Successful cancer therapy using replicating viral vectors relies on the spread of virus from infected to uninfected cells. To date, there has been limited clinical success in the use of replicating adenoviruses. In animal models, established xenograft tumors are rarely eliminated despite the persistence of high viral titers within the tumor. Hypoxia is a prevalent characteristic of solid tumors, whereas adenovirus naturally infects tissues exposed to ambient oxygen concentrations. Here, we report that hypoxia (1% oxygen) reduces adenoviral replication in H1299 and A549 lung cancer cells, BxPC-3 pancreatic cancer cells, LNCaP prostate cancer cells and HCT116 colon cancer cells. However, hypoxia does not reduce cell viability or restrict S-phase entry. Importantly, the production of E1a and fiber proteins under hypoxic conditions was substantially decreased at 24 and 48 h compared to room air controls. In contrast, Northern analysis showed similar levels of E1a mRNA in room air and hypoxic conditions. In conclusion, a level of hypoxia similar to that found within solid tumors reduces the replication of adenoviral vectors by reduction of viral protein expression without a reduction in mRNA levels. To further improve oncolytic therapy using a replicating adenovirus, it is important to understand the mechanism through which hypoxia and the virus interact to control expression of viral and cellular proteins, and consequently to develop means to overcome decreased viral production in hypoxic conditions. Gene Therapy (2005) 12, 911-917.
Introduction
The use of replicating adenoviruses offers an exciting possibility in the treatment of cancer. 1, 2 The virus can be produced in high titers and has an excellent safety record in humans. 3 Yet, despite the biological advantage of replicating to high levels in cancer cells and the potential to spread from cell to cell, clinical results to date have been disappointing. 1, 2 Further, in animal models, the replicating adenovirus is rarely able to eradicate established tumors following a single direct intratumoral administration. 4, 5 Despite the failure to eliminate xenograft tumors, high viral titers can be found within tumors for several weeks following a single viral injection. 4, 6 These observations of tumor persistence, despite high titers of virus within the tumors, suggest that limitations in viral spread within established tumors may impede the therapeutic effects of replicating adenoviruses.
Many physical barriers found within an organized tumor could potentially contribute to the inability of adenovirus to spread. The extracellular matrix is one possibility. It is not known whether adenovirus is able to diffuse freely through the various components of the matrix. Previously described experiments of successful viral spread when infected and uninfected tumor cells are mixed at the time of initial tumor establishment suggest that tumor supporting elements might prevent the efficient spread of adenovirus. 4 Adenoviral infection is primarily mediated by an interaction of the virus with the coxsackieadenovirus receptor (CAR) and an integrin receptor on the cell surface. 7 The expression of CAR is highly variable within different tumors, 8 suggesting that downregulation of this receptor could be another potential barrier for the replication and spread of adenovirus. 9 It is of interest that the surface epithelia that are naturally infected by adenovirus, that is, the respiratory epithelium and conjunctiva, are exposed to ambient and therefore higher levels of oxygen (150 mmHg) compared to most other tissues. Furthermore, tissue hypoxia is a well-characterized feature of solid tumors. 10 Normally oxygenated tissues have an oxygen concentration of 50-60 mmHg, whereas most solid tumors have oxygen concentrations of 10 mmHg or less. [10] [11] [12] The hypoxic environment has an important effect on tumor growth and it reduces tumor response to chemotherapy and radiation therapy. 10 Tumors with lower pO 2 values also confer significantly lower probability of 5-year survival on the host. 13 In addition, the fact that blood vessels within a tumor can on occasions be seen surrounded by virus-infected cells implies that the bloodstream, or the capillary, provide a factor important for viral replication. 6 Considering that adenovirus naturally infects welloxygenated areas and has been found topographically in close proximity to the vasculature within tumors, the hypoxic environment within tumors might present an obstacle for replication and spread of adenoviruses.
The goal of this project was to elucidate whether a level of hypoxia similar to that found within the tumor environment presents a significant barrier to viral replication. Hypoxia is shown to decrease viral replication within tumor cells, without restricting the entry of these cells into S-phase. Furthermore, the decrease in viral replication is associated with a decrease in the expression of viral proteins, but viral transcription remains unchanged.
Results

Hypoxia induces HIF-1a expression
To test whether our experimental conditions set at 1% oxygen rendered a hypoxic response, HIF-1a expression was evaluated. HIF-1a is a transcription factor that plays a central role in cellular adaptation to decreased oxygen concentration.
14 In conditions of ambient oxygen tension, the von Hippel-Lindau gene product interacts with HIF1a. This interaction leads to the ubiquitin-mediated proteosomal degradation of HIF-1a. However, under hypoxic conditions, HIF-1a is stabilized and translocated into the nucleus where it binds to enhancer elements within the promoters of hypoxia-responsive genes such as VEGF and erythropoietin, and thereby initiates their transcription.
In the two lung adenocarcinoma cell lines (H1299 and A549) used in this study, HIF-1a protein expression was increased ( Figure 1 ) in hypoxic conditions (1% oxygen concentration) compared to ambient conditions (21% oxygen concentration). This experiment therefore confirms that the hypoxic conditions that were used for the following experiments induced a physiological response.
Hypoxia reduces viral replication
Adenovirus naturally infects tissues that are exposed to ambient oxygen concentrations and cause mild respiratory or conjunctival infections. 15 The conditions within a tumor are very different, with oxygen concentrations approximating 10 mmHg or lower. 10, 11 To determine whether hypoxia limits the replication of wild-type adenovirus, the production of new virus was evaluated under ambient or hypoxic (1% oxygen) conditions. For H1299, A549 and LNCaP cells, new virus production was significantly diminished (Po0.05) after 48 h under hypoxic conditions compared to the virus production in ambient oxygen (Figure 2 This level of hypoxia did not reduce cell viability, which was evaluated by trypan blue exclusion (data not shown).
Hypoxia does not reduce the proportion of cells in S-phase
It has been previously demonstrated by different investigators that hypoxia causes cell cycle growth arrest in nontransformed cells. [16] [17] [18] Although the exact mechanism is still debated, hypoxia generally reduces the activity of cyclin-dependent kinases, which leads to hypophosphorylation of the Rb protein and growth arrest in G1. [16] [17] [18] Moreover, the presence of cells in S-phase may be important to enable adenoviral replication. 19, 20 To Figure 1 HIF-1a is expressed under hypoxic conditions. H1299 and A549 cancer cell were placed in 1% (lanes 1 and 3) or ambient oxygen (lanes 2 and 4) and harvested after 3 h incubation. Immunoblotting was performed against HIF-1a. Exposure to CoCl 2 was used as a positive control (lane 5). H1299 and A549 cells are shown to express increased levels of HIF-1a in hypoxic conditions.
Figure 2 Viral replication is significantly decreased under hypoxic conditions. H1299, A549 and LNCaP cells were infected with wild-type adenovirus Ad309 at an MOI of 10. Cells were incubated for 2 h under ambient oxygen. After 2 h, the virus was removed and cells were placed at either ambient or hypoxic conditions. After 48 h of incubation, cells were harvested and titer was determined using a rapid titration assay. For all cell lines, viral yield was significantly decreased (Po0.05) in 1% oxygen compared to ambient conditions.
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investigate whether the decrease in viral production seen in hypoxic conditions was associated with G1 cell arrest, cell cycle distribution was evaluated by FACS analysis after propidium iodide staining. Interestingly, hypoxia had no effect on S-phase distribution of uninfected A549 cells, which showed 11(72)% of cells in S-phase in ambient conditions compared to 11(71)% in hypoxia. Surprisingly, there was an increase in S-phase distribution for H1299 cells in hypoxia, which showed 31(72)% of cells in S-phase in ambient oxygen compared to 44(73)% in hypoxia ( Figure 3) . Hypoxia, however, induced normal human umbilical vein endothelial cells (HUVEC) to undergo a G1 growth arrest as anticipated. In ambient conditions, 10(72)% of cells were in S-phase versus 1(71)% under hypoxia ( Figure 3 ). Virus-infected A549 and H1299 cells showed an increased proportion of cells in S-phase under hypoxic conditions and ambient oxygen compared to uninfected cells (data not shown). Therefore, the decreased viral production observed in A549 and H1299 cancer cells under hypoxic conditions is not due to a decrease in the proportion of cells in S-phase.
Hypoxia reduces viral protein expression
It has been shown that under extreme hypoxia, the rate of cellular protein synthesis is reduced. [21] [22] [23] We sought to determine whether translation of viral and host cell proteins is affected by the conditions of hypoxia that we used, and might thus account for the reduction in virus production. In H1299, A549, LNCaP and HCT116 cells, there was a substantial decrease in the levels of two viral proteins, E1A and fiber, after exposure to hypoxia (1% oxygen) for 24 or 48 h (Figure 4) . However, levels of the host cell protein b-actin did not decrease after 24 or 48 h of exposure to hypoxia (Figure 4 ). These data suggest that the decreased viral production that is seen under hypoxic conditions is the result of a decrease in viral protein levels.
To further substantiate these findings, a protein pulselabeled experiment was performed in H1299 cells ( Figure  5 ). A substantial decrease in all of the visible viral proteins is seen after exposure to hypoxia. However, the change in the levels of cellular proteins in virus-infected cells under hypoxic conditions is less dramatic, in agreement with the immunoblotting studies.
Hypoxia does not reduce mRNA transcription
In order to determine whether the decreased viral production observed under hypoxic conditions was due to a decrease in the levels of viral mRNA, Northern analysis was performed for E1A mRNA. For both H1299 and A549 cells, the level of E1A mRNA was similar for cells exposed to ambient or 1% oxygen after 24 h. b-actin mRNA levels were also similar for hypoxic and ambient conditions ( Figure 6 ). These data, therefore, show that the reduction in new virus production and the decreased levels of viral proteins seen in hypoxic conditions does not result from reduced mRNA levels. Figure 3 The proportion of cells in S-phase is not decreased in hypoxia. H1299, A549 and HUVEC cells were incubated in 1% or ambient oxygen for 48 h. Cells were harvested and subjected to FACS analysis after incubation with propidium iodide. The proportion of both H1299 and A549 cells in S-phase was not decreased in hypoxic conditions. However, normal HUVEC cells were growth arrested in hypoxic conditions. 
Discussion
The use of replicating adenoviral vectors for cancer gene therapy is an exciting concept; however, the results to date in clinical trails have been disappointing. 1, 2, 24, 25 Of interest, in xenograft models, limited efficacy does not result from clearance of the virus from the tumor. Replicating virus can persist within xenograft tumors that show a partial therapeutic response for several weeks. 4, 6 It is, therefore, important to understand the barriers within an established tumor that limit the spread and replication of the adenovirus.
Hypoxia is a well-characterized feature of solid tumors, 10 and the hypoxic environment has an important but detrimental effect on the response of tumors to both chemotherapy and radiation therapy. 10 In a previous study, it was demonstrated that in xenograft tumors, virus-infected cells are topographically associated with blood vessels. 6 This finding, together with the observation that adenovirus naturally targets tissues exposed to ambient oxygen concentrations, 15 suggests that hypoxic conditions could affect viral replication.
In this study, we report that in five carcinoma cell lines exposed to the level of hypoxia that would be expected within a tumor, there was a decrease in viral replication as measured by the production of new virus. This finding has obvious implications for the use of replicating adenoviruses as therapeutic agents for solid tumors. In addition, this finding also suggests that decreased viral replication may be an obstacle for strategies designed to target viral replication to hypoxic regions within tumors.
To determine the mechanism of decreased virus production, we first examined if hypoxia affected the H1299 and A549 cells were infected with Ad309 at an MOI of 10 (+) for 2 h at ambient oxygen or remained uninfected (À). After 2 h, the virus was removed and cells were incubated at 1% (lanes 1 and 2) or ambient oxygen (lanes 3 and 4) for 24 h. Cells were harvested for Northern analysis for E1a mRNA levels. For both H1299 and A549 cells, the level of E1a mRNA was similar for cells exposed to both ambient or 1% oxygen. Actin levels were also similar.
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T Pipiya et al cell cycle distribution of tumor cells. It has previously been shown that the cell cycle distribution of cells at the time of infection may be an important determinant in the outcome of viral infection. 19, 20 The viral E1a protein by interactions with pRb and p300 induces S-phase, and this has been reported to be important for optimal viral replication. 5, 26 Further, it has been previously demonstrated that hypoxia causes cell cycle growth arrest in G1 in nontransformed cells. [16] [17] [18] Our data, however, show that the reduced viral yield under hypoxic conditions was not due to cell cycle arrest of tumor cells. Although as anticipated, hypoxia was able to growth arrest normal HUVEC, hypoxia did not growth arrest the cancer cells. For the two cell lines studied, cell cycle analysis showed a similar proportion of A549 cells in S-phase in ambient or hypoxic conditions. For H1299 cells, there was even a slight increase of cells in S-phase under hypoxia compared to ambient conditions. A similar finding of increased S-phase in hypoxic conditions has been reported in cells with disrupted HIF-1a signaling. 16 We next sought to determine if hypoxia affects the production of viral proteins or viral mRNA. After 24 or 48 h of exposure to hypoxia, the two viral proteins evaluated, E1A and fiber, were downregulated compared to controls in ambient conditions. The levels of the host cell protein b-actin, however, did not differ between hypoxia and ambient conditions at 24 or 48 h. Similar findings were observed for several viral and cellular proteins in a protein pulse-labeling experiment in H1299 cells. The decrease in viral protein levels, therefore, corresponds with the decrease in new virus production. Interestingly, Northern analysis for mRNA levels showed similar levels of E1a mRNA under both hypoxia and ambient oxygen concentrations. Actin mRNA levels were also similar in hypoxia and ambient conditions. Hypoxia, therefore, appears to decrease the production of new virus by decreasing the synthesis of viral proteins. This could potentially be due to hypoxia selectively affecting the translation of viral proteins, or possibly hypoxia could cause a global turn-off of host cell translation, which may not be evident on the immunoblots because actin has a relatively long half-life. The protein pulse-labeling experiment, however, also suggests a more substantial decrease in viral compared to host cell translation in the virus-infected hypoxic cell within 48 h of infection.
The control of translation under hypoxic conditions, and in the adenovirus-infected cell is complex. Hypoxia has been reported to act through different mechanisms to initiate translational turn-off. One study has suggested that exposure of cells to hypoxia leads to translational turn-off via an increased phosphorylation of the translational initiation factor eIF2a that is mediated by the endoplasmic reticulum resident kinase (PERK). 22 Another study has demonstrated that hypoxia leads to a rapid hypophosphorylation of mammalian target of rapamycin and its effectors such as 4E-BP1 and eukaryotic initiation factor 4G (eIF4G), 23 also leading to translational turn-off but by sequestration of cap binding protein eIF4E.
Translational turn-off is also an innate cellular response to viral infection, and viruses have developed many mechanisms to overcome this. 27 Adenovirus can overcome PKR-mediated translational shut off, which is stimulated by interferon and double-stranded RNA and mediated by phosphorylation of eIF2a by the expression of adenoviral VA RNA. 27 Furthermore, adenovirus itself turns-off translation of host cell proteins late in the infection cycle by dephosphorylation of the eIF4E cap binding protein. Late viral proteins can still be translated because late viral mRNAs contain a tripartite leader that utilizes a modified cap initiation complex containing the viral 100 kDa protein. 28 In conclusion, we have demonstrated that hypoxia significantly limits the replication of the adenovirus in cancer cells. This reduction in virus production in cancer cells in hypoxic conditions is not mediated by cell cycle arrest in G1, because unlike normal cells, the cancer cells studied did not undergo a G1 growth arrest. Furthermore, the effect of hypoxia on virus production is mediated by a reduction in viral protein levels, but not reduced viral mRNA transcription. Hypoxia therefore presents a barrier to replication and spread of adenovirus in established tumors, which may result in limited success in eradication of solid tumors. To further improve oncolytic therapy using a replicating adenovirus, it is important to understand the mechanism through which hypoxia and the virus interact to control translation of viral and cellular proteins, and consequently develop means to overcome decreased viral production in hypoxic conditions.
Materials and methods
Cell lines and culture
Cancer cell lines were obtained from American Type Culture Collection, Manassas, VA, USA. A549 lung adenocarcinoma cells were cultured in Ham's F12K medium containing 10% fetal bovine serum (FBS) and antibiotics (penicillin (25 U/ml), streptomycin (25 mg/ ml)). H1299 non-small-cell lung cancer cells, LNCaP prostate cancer cells and BxPC-3 pancreatic cancer cells were cultured in RPMI 1640 medium with 4.5 g/l glucose, 1.0 mM sodium pyruvate plus 10% FBS and antibiotics. HCT116 colon cancer cells were cultured in McCoy's medium supplemented with 10% FBS and antibiotics. HUVEC were purchased from Cambrex Bio Science Baltimore Inc. (Baltimore, MD, USA) and cultured in EGMt-Endothelial Cell Medium.
Adenoviruses
Ad309 was used in these studies. 29 Viruses were amplified on 293 cells, purified and titered following standard protocols 30, 31 and suspended in vehicle (10 mM Tris (pH 7.4), 1 mM MgCl2, 10% (v/v) glycerol).
Hypoxia
For this study, hypoxia is defined as 1% oxygen, which is approximately 7 mmHg. For all experiments, cells were grown on 100 mm tissue culture dishes with 2 Â 10 6 cells/plate for 24, 48 or 72 h at either ambient oxygen and 5% CO 2 or 1% oxygen concentration with 5% CO 2 . Hypoxia was established using a HERAcell 150 incubator, which uses N 2 and CO 2 gases to obtain a required oxygen concentration (Kendro Laboratory products, Newtown, CT, USA).
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Immunoblotting
Cell infection and lysate preparation were performed as described previously. 32 Total protein concentration was determined using the BCA protein assay (Pierce, Rockford, IL, USA), and equal amounts of protein were electrophoresed on a denaturing 10% polyacrylamide gel. Proteins were transferred by electroblotting to a PVDF membrane (Immobilon-P, Millipore, Bedford, MA, USA). Nonspecific binding was blocked in 5% milk in PBS-t (0.1% Tween-20). Antibodies were incubated in 2.5% milk in PBS-t. The monoclonal antibody to E1a (Ab-2, Neo Markers, Freeport, CA, USA) was used at a dilution of 1:500. The monoclonal antibody to HIF-1a (BD Transduction Laboratories, San Diego, CA, USA) was used at a dilution 1:100. The goat polyclonal antibody to b-actin protein (Santa Cruz, Santa Cruz, CA, USA) was used at a dilution 1:200. The adenovirus fiber antibody Ab-4 (4D2, Neo Markers, Freeport, CA, USA) was used at a dilution of 1:5000. The appropriate anti-mouse or anti-goat antibody (Santa Cruz) was used at a dilution of 1:500 for HIF-1a and actin, 1:1000 for E1A and 1:10 000 for fiber immunoblots. Antibody binding was visualized by enhanced chemiluminescence following the manufacturer's instructions (SuperSignal West Pico Chemiluminescent Substrate, Pierce, Rockford, IL, USA).
Viral yield assay
Viral yield was determined as described previously. 32 In brief, cells were virus infected in 100 mm plates with 10 PFU/cell for 2 h with wild-type adenovirus Ad309. After 2 h, the virus was removed and the cells were placed in an ambient oxygen incubator or the hypoxic incubator with 1% oxygen tension. Cells were harvested with a cell scraper at 48 or 72 h. Samples were freezethawed three times and centrifuged. The supernatant was titered by serial dilution on 293 cells, using a modified plaque assay. At 48 h after the addition of the diluted crude viral lysate, cells were fixed with methanol and incubated with an anti-adenovirus Ab (Chemicon International, Temecula, CA, USA) at a dilution 1:500 in PBS plus 1% BSA, 400 ml/well for 2 h at 371C on a rotator. Cells were washed three times with PBS plus 1% BSA and then incubated with anti-mouse IgG-HRP (Santa Cruz) at a 1:1000 dilution in 400 ml for 1 h at 371C on a rotator. Cells were consequently washed with PBS plus 1% BSA three times for 5 min and stained with 3,3 diaminobenzidine tablets dissolved in 15 ml PBS plus 12 ml of 30% hydrogen peroxide (Sigma, St Louis, MO, USA) for 20 min or until color developed. Positive stains were observed and counted.
Cell cycle analysis
Cell cycle distribution of cells exposed to ambient or hypoxic conditions was evaluated. H1299, A549 and HUVEC cells were either infected with Ad309 (10 PFU/ cell) or uninfected and exposed to either ambient oxygen concentration or 1% oxygen for 48 h. Cells were washed with PBS, trypsinized with 0.05% trypsin and the cell pellet was fixed in 5 ml of 100% ice-cold ethanol overnight. Cells were stained with propidium iodide (Sigma). The DNA content was measured by flow cytometry (Vantage, Becton Dickinson Immunocytometry Systems, San Jose, CA, USA). Data were analyzed with Modfit LTt (Verity Software House, Topsham, ME, USA).
Northern blot
Cells were harvested after incubation at ambient or 1% oxygen at 24 h. RNA was extracted according to the manufacturer's protocol (Invitrogen Life technologies, Carlsbad, CA, USA). Samples were run on 1% denaturing agarose gel and then transferred onto a Hybond-N+ membrane (Amersham Pharmacia Biotech, Buckinghamshire, England) using Turboblotter downward transfer assembly (Laboratory Disposable Products, Haledon, NJ, USA). The damp membrane was crosslinked by ultraviolet light using CL-100 Ultraviolet Crosslinker (UVP, San Gabriel, CA, USA). E1A and b-actin probes were generated by digesting plasmids containing the E1A or b-actin cDNA with appropriate enzymes followed by DNA extraction from agarose gels according to the manufacturer's protocol (Qiagen Inc., Valencia, CA, USA). Probes were labeled with [ 32 P]dCTP using Prime-It Random Prime Labeling Kit according to the manufacturer's protocol (Stratagen, La Jolla, CA, USA). Northern blot was performed using NorthernMax formaldehyde-based system according to the manufacturer's protocol (Ambion Inc., Austin, TX, USA). The image was obtained on a phosphoimager (Molecular Dynamics) using ImageQuant software.
Evaluation of protein synthesis
H1299 cells were seeded at 2 Â 10 6 cells per plate and infected at an MOI of 10 with Ad309 or remained uninfected. After 2 h, the media were changed and plates were placed in 1% oxygen or remained in ambient conditions. At 42 h following infection, 2 ml of methionine-free medium containing [ 35 S]methionine (100 mCi per plate; Perkin-Elmer, Boston, MA, USA) was added to the existing 4 ml of media without interruption of the hypoxic conditions and incubated for 6 h. Cells were harvested, rinsed with PBS and suspended in ice-cold radioimmunoprecipitation assay buffer, and DNA was sheared through a 21-G needle. Lysates were incubated on ice for 30 min and debris pelleted by microcentrifugation at 15 000 g for 20 min at 41C. The proteins (25 ml, equivalent to 125 000 cells) were separated by polyacrylamide gel electrophoresis. The gel was fixed in isopropanol:acetic acid:water (125:50:325, v/v/v) and incubated in Amplify (Nycomed Amersham, Piscataway, NJ, USA) for 20 min to enhance the signal before autoradiography.
Statistics
Standard errors are reported and shown in the figures. Mean values between groups were compared using the paired two-tailed Student's t-test.
